跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NOXAFIL posaconazole 40mg/mL oral suspension bottle - TGA Drug Approval Details
Approvals
/
TGA
/
NOXAFIL posaconazole 40mg/mL oral suspension bottle
Approved
STANDARD
NOXAFIL posaconazole 40mg/mL oral suspension bottle
Merck Sharp & Dohme (Australia) Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
3ceb01b4b0e4f111
Company
Merck Sharp & Dohme (Australia) Pty Ltd
Type
Standard
Approval Details
Approval Id
3ceb01b4b0e4f111
Product Name
NOXAFIL posaconazole 40mg/mL oral suspension bottle
Artg Id
115556
Artg Name
NOXAFIL posaconazole 40mg/mL oral suspension bottle
Sponsor
Merck Sharp & Dohme (Australia) Pty Ltd
Company Detail Path
/organization/merck-sharp-and-dohme-australia-pty-ltd
Artg Date
2006-03-15
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/cc0c0e0e56fd142c33003f28a7b850d2.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/97e75d40860f6b7444afcbef8b1ba29c.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
3ceb01b4b0e4f111
Type
Standard
Back to TGA Approvals